According to the status of hormone receptors [estrogen receptor (ER) and progesterone receptor (PR)] and HER2, BC can be classified into three primary subtypes: Luminal ER-positive and PR-positive, which can be further categorized as luminal A and B, HER2-positive BC and TNBC (14,15). This evidence concerns the gene NR4A1 and breast cancer.